Clinical Director Of Studies For Medicine at Deep Dementia Phenotyping (DEMON) Network
Cambridge, England, United Kingdom
Join Prog.AI to see contacts
Join Prog.AI to see contacts
Summary
👤
Senior
🎓
Top School
Timothy Rittman is a clinician-scientist and neurologist with 13 years' experience leading clinical research into rare dementias, combining neuroimaging, cognitive phenotyping and neuropathology to map how these diseases affect the whole brain. As Clinical Director of Studies for Medicine at Peterhouse and a Senior Clinical Research Associate at the University of Cambridge, he translates AI and big-data neuroimaging methods into tools for memory clinics while also running specialist clinics for PSP, corticobasal degeneration and dementia genetics at Addenbrooke’s. He co-leads the DEMON Network Imaging Working Group and serves as NIHR neurodegeneration specialty lead for the East of England, reflecting a rare mix of hands-on patient care, academic leadership and regional research coordination. His background includes a PhD in Clinical Neuroscience and early global-health advocacy and training roles, evidencing both methodological depth and a long-standing commitment to medical education and service development.
13 years of coding experience
3 years of employment as a software developer
PgCertMedEd, Medical Education, PgCertMedEd, Medical Education at University of Dundee
Obstetrics and Gynaecology, Paediatrics, Obstetrics and Gynaecology, Paediatrics at University of Oslo
Doctor of Philosophy (Ph.D.), Clinical Neuroscience, Pass, Doctor of Philosophy (Ph.D.), Clinical Neuroscience, Pass at University of Cambridge
MRCP (UK), Medicine, MRCP (UK), Medicine at Royal College of Physicians
BMBS, Medicine, BMBS, Medicine at University of Nottingham
Contributions:49 pushes, 1 branch in 3 years 3 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Timothy Rittman - Clinical Director Of Studies For Medicine at Deep Dementia Phenotyping (DEMON) Network